NDAOPHTHALMICSOLUTION/DROPS
Approved
Mar 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 12h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VISINE L.R. is an over-the-counter ophthalmic decongestant containing oxymetazoline hydrochloride, a selective alpha-1 adrenergic agonist that constricts blood vessels in the eye. It is used to relieve redness, irritation, and congestion associated with minor eye conditions. The extended-relief formulation provides symptom management for up to 8 hours.
LOE Approaching
Product is in late lifecycle stage with moderate competitive pressure (30%), indicating smaller brand teams focused on market defense rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
Started Apr 2019
1,105 enrolled
Rosacea
Career Relevance
Working on VISINE L.R. offers career experience in mature-market brand stewardship, OTC commercialization, and competitive positioning in a stable but low-growth category. Roles emphasize operational efficiency, market defense, and consumer engagement rather than innovation or clinical advancement, making this suitable for professionals seeking stability over high-growth trajectory.
Brand Manager
Worked on VISINE L.R. at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.